PET scan test for early lung scarring
Treatments studied
Part of Lungs & breathing clinical trials.
This trial uses a special PET/MRI scan to look for early signs of lung scarring and inflammation using a “collagen-targeting” tracer. It may help doctors better identify early interstitial lung disease (IL D) and track it over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 40 years
- Be able to sign informed consent (meaning you can understand and agree to the study)
- For study group 1: have a first-degree family member with pulmonary fibrosis, and you personally have no known interstitial lung disease
- For study group 2: have early lung changes called ILAs or early ILD (not a definite UIP pattern, with certain CT findings like reticular markings and/or traction bronchiectasis)
- No tobacco use in the past 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced imaging to see how immunosuppressive medications (like mycophenolate or prednisone) affect lung scarring in patients with certain types of lung fibrosis. You would have imaging scans and breathing tests to track changes over time.
This study tests a new imaging method that may help doctors see whether certain types of lung scarring are linked to memory and thinking issues. If you have a chronic lung condition and also notice memory problems, this scan could give more information about your condition.
This study tests whether a new PET/CT scan using a radioactive tracer called FAPI-46 can better see lung changes in people with interstitial lung disease. It might help doctors understand the disease activity better.
This study tests a new imaging scan (called 18F-FAPI PET/CT) that may help detect scarring in the lungs, heart, or blood vessels. If you have a heart, lung, or blood vessel condition that could cause scarring, this scan might show damage earlier and help doctors plan better treatment.
This trial tests how well a CT scan and lung function tests can measure interstitial lung disease (ILD), which is long-term scarring or inflammation in the lungs. It may help doctors use these images and tests more accurately to track ILD.
This Phase 1 study tests a radioactive imaging agent to help doctors see disease activity in the lungs using PET/MRI scans. It includes healthy volunteers and people with lung cancer, idiopathic pulmonary fibrosis, lung transplant–related lung problems, or certain medication-related lung inflammation.
Hear when a new Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.